Bruno Geloneze
Bruno Geloneze
Professor of Endocrinology and Diabetes, Obesity and Comorbities Research Center UNICAMP Brazil
E-mail confirmado em
Citado por
Citado por
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
ISE Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, Mattheus ...
New England Journal of Medicine 373 (22), 2117-28, 2015
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
M SP, D GH, Brown-Frandsen K, K P, M JF, N MA, N SE, P S, P NR, R LS, ...
New England Journal of Medicine 375 (4), 311-322, 2016
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
MKW Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM ...
New England Journal of Medicine 380 (24), 2295-2306, 2019
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
MM Wanner C1, Inzucchi SE1, Lachin JM1, Fitchett D1, von Eynatten M1, ...
New England Journal of Medicine 375 (4), 323-334, 2016
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
WJP Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau ...
New England Journal of Medicine 373 (1), 11-22, 2015
Liraglutide and Renal Outcomes in Type 2 Diabetes
BJB Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S ...
New England Journal of Medicine 377 (9), 839-848, 2017
Pratical recommendations for the management of diabetes in patients with COVID-19
SR Bernstein, F Rubino, K Khunti, G Mingrone, D Hopkins, AL Birkenfeld, ...
The Lancet Diabetes & Endocrinology, 00, 2020
IV Diretriz brasileira sobre dislipidemias e prevenção da aterosclerose: Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia
AC Sposito, B Caramelli, FAH Fonseca, MC Bertolami, A Afiune Neto, ...
Arquivos brasileiros de cardiologia 88, 2-19, 2007
Long-term weight regain after gastric bypass: a 5-year prospective study
DO Magro, B Geloneze, R Delfini, BC Pareja, F Callejas, JC Pareja
Obesity surgery 18 (6), 648-651, 2008
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
PSX le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DC, Van Gaal L, Ortiz ...
Lancet 140 (17), 30069-7, 2017
The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 …
MLMP Jorge, VN de Oliveira, NM Resende, LF Paraiso, A Calixto, ...
Metabolism 60 (9), 1244-1252, 2011
I Diretriz sobre o consumo de gorduras e saúde cardiovascular
RD Santos, ACM Gagliardi, HT Xavier, CD Magnoni, R Cassani, ...
Arquivos Brasileiros de Cardiologia 100, 1-40, 2013
TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study
ACJ Vasques, FS Novaes, MS de Oliveira, JRM Souza, A Yamanaka, ...
Diabetes research and clinical practice 93 (3), e98-e100, 2011
HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS)
B Geloneze, ACJ Vasques, CFC Stabe, JC Pareja, LEFP Rosado, ...
Arquivos Brasileiros de Endocrinologia & Metabologia 53 (2), 281-287, 2009
Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26 …
BMK Russell-Jones D, Cuddihy RM, Hanefeld M, Kumar A, González JG, Chan M ...
Diabetes Care 35 (2), 252-8, 2012
The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study.
B Geloneze, EM Repetto, SR Geloneze, MA Tambascia, MN Ermetice
Diabetes Research and Clinical Practice 72 (2), 219, 2006
Neck Circumference as a Simple Tool for Identifying the Metabolic Syndrome and Insulin Resistance: Results from the Brazilian Metabolic Syndrome Study (BRAMS)
C Stabe, ACJ Vasques, MMO Lima, MA Tambascia, JC Pareja, ...
Clinical Endocrinology, 2012
Ghrelin: a gut-brain hormone: effect of gastric bypass surgery
B Geloneze, MA Tambascia, VF Pilla, SR Geloneze, EM Repetto, ...
Obesity surgery 13 (1), 17-22, 2003
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
PV Jardine MJ, Mahaffey KW, Neal B, Agarwal R, Bakris GL, Brenner BM, Bull S ...
American Journalof Nephrology 46 (6), 462-472, 2017
Avaliação laboratorial e diagnóstico da resistência insulínica; Laboratorial evaluation and diagnosis of insulin resistance
B Geloneze, MA Tambascia
Arq. bras. endocrinol. metab 50 (2), 208-215, 2006
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20